Germany's CureVac jab returns 47% efficacy in interim trial results
The European Union has secured up to 405 million doses of the CureVac vaccine. (Photo Credits: Unsplash)
The company blamed the "unprecedented context of at least 13 variants"
For Phase 2b/3 CureVac studied 40,000 people in 10 countries
CureVac initially expected to seek European approval for its jab
View Full Post